Eribulin Mesylate in Treating Patients With Previously Treated Metastatic Breast Cancer

Clinical trial NCT01908101 · COMPLETED

Trial details

NCT number: NCT01908101
Sponsor: University of Washington
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Breast Carcinoma Stage IV Breast Cancer

Start date: 2014-01-08
Primary completion: 2019-05-04
Enrollment: 86

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.